Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Catheter ablation to treat supraventricular tachycardia (SVT) is not detrimental to patients

This data refutes previous evidence which suggested a high incidence of injury to a patient's cardiac nerves, possibly resulting in accelerated heart rates following the procedure.

31 Jan 2005

Startling results from new biomedical research will smooth path to the market place

Researchers have discovered how to convert liver cells of mice into pancreatic cells using a single injection. This may eventually lead to a cure for diabetes. Dr. James Mittra, one of the organisers of an international conference in Edinburgh on the Evolution of the Life Science Industries asks, “How does the pharmaceutical industry respond to this kind of work? They are primarily interested in treatments, not cures. Do they see this kind of research as a threat?”

27 Jan 2005

Breakthrough in identifying causes and treatment for degenerative neurological diseases

A new, high resolution x-ray scanning technique that can look inside a single brain tissue cell, is a major step forward in identifying the role of iron and other metals in degenerative neurological diseases such as Alzheimer’s and Parkinson’s.

24 Jan 2005

Two minutes of magnetic stimulation can change your brain for an hour

A couple of minutes is all it takes to ‘knock out’ bits of your brain for an hour, according to a new study by a University College London (UCL) team.

19 Jan 2005

Catheter ablation safe for patients

A recent study published in Pacing and Clinical Electrophysiology (PACE) determined that the use of catheter ablation to treat supraventricular tachycardia (SVT) is not detrimental to patients.

19 Jan 2005

Single gene mutation as the cause of around one in 25 cases of Parkinson’s disease worldwide

The studies suggest that the mutation, in a recently discovered gene called LRRK2, causes around 5% of inherited Parkinson’s cases and around 2% of isolated cases. Screening for the new mutation is likely to become a component of genetic testing for Parkinson’s disease in the near future.

17 Jan 2005

Botox may help people with movement disorders

The long-term effects of botulinum toxin type A (Botox) in patients with severe movement disorders confirm the safety of the toxin's use in controlled dosages, according to a recent study at Baylor College of Medicine in Houston.

17 Jan 2005

Significant advance in understanding the human genome

An Oregon Health & Science University-led development of a technique for identifying control elements that drive the expression of genes in brain cells could unleash the disease-fighting potential of the much-hailed human genome.

28 Dec 2004

Paclitaxel may benefit Alzheimer's and Parkinson's movement disorders

Angiotech Pharmaceuticals have announced that a preclinical study published in today's early edition of the Proceedings of the National Academy of Sciences highlights the positive effects of Paxceed on movement disorders commonly seen in diseases known as taupathies, such as Alzheimer's and Parkinson's.

27 Dec 2004

Researchers can now inexpensively program the chemical synthesis of entire genes on a single microchip

Devices the size of a pager now have greater capabilities than computers that once occupied an entire room. Similar advances are being made in the emerging field of synthetic biology at the University of Houston, now allowing researchers to inexpensively program the chemical synthesis of entire genes on a single microchip.

23 Dec 2004

Botox may be a possible treatment for sufferers of Tourette's syndrome

Researchers at Baylor College of Medicine in Houston are using botulinum toxin type A (Botox) to treat the neurological disorder, which can cause involuntary motor and vocal tics.

21 Dec 2004

Theory that could help to cure diseases including cancer

An Open University science student has astonished the world of medicine with a theory that could help to cure diseases including cancer.

21 Dec 2004

Annual decline in cognitive functioning is similar in patients with Parkinson disease and dementia and patients with Alzheimer disease

The average annual decline in cognitive functioning is similar in patients with Parkinson disease (PD) and dementia and patients with Alzheimer disease (AD), according to an article in the December issue of The Archives of Neurology, one of the JAMA/Archives journals.

13 Dec 2004

Cell replacement therapy offers a novel and powerful medical technology

Cell replacement therapy offers a novel and powerful medical technology. A type of embryonic stem cell, called a neural crest stem cell, that persists into adulthood in hair follicles was recently discovered by Maya Sieber-Blum, Ph.D., of the Medical College of Wisconsin, Milos Grim, MD Ph.D., of Charles University Prague, and their collaborators.

13 Dec 2004

Trimming fat overcomes one of the major obstacles to drug design

Biochemists at Ohio State University and their colleagues have overcome one of the major obstacles to drug design, by trimming some of the fat from a molecular sponge that scientists use to study proteins.

8 Dec 2004

Neurobiologists distinguish in unprecedented detail the patterns of brain activity

Using hairlike microelectrodes and computer analysis, neurobiologists at Duke University Medical Center have demonstrated that they can see the detailed instant-to-instant electrical "brainscape" of neural activity across a living brain.

8 Dec 2004

Episome vectors offer fresh angle to gene therapy

A European research team is seeking to overcome the early setbacks suffered by the promising new field of ‘gene therapy’ by developing a revolutionary delivery technique, known as ‘episome vectors’. This breakthrough could pave the way to treating hereditary diseases by injecting the body with healthy versions of damaged genes.

6 Dec 2004

A step closer to medical treatments for neural disorders

New insight into the role of a key regulator in cell division may help uncover new drug targets in the search for treatments for neural disorders such as Parkinson's and Huntington's disease.

29 Nov 2004

Rifampicin can prevent the formation of protein fibrils associated with Parkinson's disease

Researchers at the University of California, Santa Cruz, have shown that rifampicin, an antibiotic used to treat leprosy and tuberculosis, can prevent the formation of protein fibrils associated with the death of brain cells in people with Parkinson's disease. The drug also dissolved existing fibrils in laboratory tests.

29 Nov 2004

Movies help explain how proteins gather into clusters called amyloid fibrils

To get a better look at how proteins gather into clusters called amyloid fibrils – which are associated with important human diseases such as Alzheimer’s, Parkinson’s and the so-called prion diseases like Mad Cow – researchers at North Carolina State University decided to make movies.

23 Nov 2004

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Catheter ablation to treat supraventricular tachycardia (SVT) is not detrimental to patients

Startling results from new biomedical research will smooth path to the market place

Breakthrough in identifying causes and treatment for degenerative neurological diseases

Two minutes of magnetic stimulation can change your brain for an hour

Catheter ablation safe for patients

Single gene mutation as the cause of around one in 25 cases of Parkinson’s disease worldwide

Botox may help people with movement disorders

Significant advance in understanding the human genome

Paclitaxel may benefit Alzheimer's and Parkinson's movement disorders

Researchers can now inexpensively program the chemical synthesis of entire genes on a single microchip

Botox may be a possible treatment for sufferers of Tourette's syndrome

Theory that could help to cure diseases including cancer

Annual decline in cognitive functioning is similar in patients with Parkinson disease and dementia and patients with Alzheimer disease

Cell replacement therapy offers a novel and powerful medical technology

Trimming fat overcomes one of the major obstacles to drug design

Neurobiologists distinguish in unprecedented detail the patterns of brain activity

Episome vectors offer fresh angle to gene therapy

A step closer to medical treatments for neural disorders

Rifampicin can prevent the formation of protein fibrils associated with Parkinson's disease

Movies help explain how proteins gather into clusters called amyloid fibrils

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in